S6B291 (S6B291_HUMAN) Homo sapiens (Human)
IgG H chain UniProtKBInterProInteractive Modelling
466 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
30 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Trastuzumab Fab v3 in complex with CQFDLSTRRLKC |
Heteromer P01834; P02976; Q51918; | 73.96 | ||||
Crystal structure of a Fab binding to extracellular domain 5 of Cadherin-6 |
Heteromer P01834; P55285; | 84.69 | 2×A2G; | |||
Clostridium difficile TcdB-GTD bound to PA41 Fab |
Heteromer Q8TCD0; | 72.43 | ||||
LINGO-1/Li81 Fab complex |
Heteromer Q6PIL8; Q96FE5; | 91.82 | 6×NAG; 4×NAG; 4×NAG; | |||
Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and C… |
Heteromer P0DOY2; | 74.19 | 2×GOL; 1×MG; | |||
Trastuzumab Fab v3 |
Heteromer P01834; P02976; Q51918; | 73.96 | ||||
Crystal structure of Pertuzumab Clambda Fab with variable domain redesign (VRD2) at 1.95A |
Heteromer P0DOY2; | 77.97 | 4×SO4; | |||
Structure of cetuximab with aminoheptanoic acid-linked N-(3-aminopropyl)-L-arginine meditope variant |
Heteromer P01834; | 56.25 | ||||
Structure of cetuximab with aminoheptanoic acid-linked N-carboxyethylarginine meditope variant |
Heteromer P01834; | 56.25 | 1×SO4; | |||
Structure of cetuximab with aminoheptanoic acid-linked n-octylarginine meditope variant |
Heteromer P01834; | 56.25 | 1×SO4; | |||
Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant |
Heteromer P01834; | 56.25 | 1×SO4; | |||
DH717.1 Fab monomer in complex with man9 glycan |
Heteromer Q6IPQ0; | 51.79 | 1×MAN; 1×GOL; | |||
Crystal structure of anti-Zika antibody Z004 bound to DENV-1 Envelope protein DIII |
Heteromer P0DOX7; Q8BE39; | 88.32 | ||||
CD22 d1-d3 in complex with therapeutic Fab Epratuzumab |
Heteromer P20273; Q8TCD0; | 47.96 | 1×NAG; 1×NAG; | |||
BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 |
Heteromer P01834; Q2N0S6; Q8TCD0; | 74.63 | 10×NAG; 18×NAG; 5×NAG; 3×NAG; 7×NAG; 1×NAG; 13×NAG; | |||
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived … |
Heteromer P04578; Q8TCD0; | 45.36 | 1×NA; | |||
Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment with a gp41 MPER-derived … |
Heteromer P04578; Q8TCD0; | 45.36 | 1×EDO; | |||
Structure of cetuximab with aminoheptanoic acid-linked N-(3-hydroxypropyl)-L-arginine meditope vari… |
Heteromer P01834; | 56.25 | 1×SO4; | |||
STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS |
Heteromer P01834; P04578; | 79.15 | ||||
Crystal structure of Z032 Fab in complex with WNV EDIII |
Heteromer P0DOX7; Q9Q6P4; | 92.73 | 2×GOL; | |||
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 |
Heteromer F5HCP3; F5HET4; P16837; Q68674; Q6GMX0; Q6SW67; | 86.64 | 1×NAG; 10×NAG; | |||
Crystal Structure of the BG505 SOSIP gp140 HIV-1 Env trimer in Complex with the Broadly Neutralizin… |
Heteromer Q2N0S6; | 42.1 | 9×NAG; 3×NAG; 18×NAG; 6×NAG; 3×NAG; 3×NAG; 18×NAG; | |||
BG505 SOSIP.664 in complex with broadly neutralizing antibodies PG9 and 8ANC195 |
Heteromer P0DOX5; Q2N0S6; Q6GMW3; Q8TCD0; | 41.67 | ||||
Crystal structure of anti-Zika antibody Z006 bound to Zika virus envelope protein DIII |
Heteromer A0A192GPS0; P0DOX7; | 88.09 | ||||
Crystal structure BG505 SOSIP gp140 HIV-1 Env trimer bound to broadly neutralizing antibodies PGT12… |
Heteromer P01834; P01857; Q2N0S6; | 72.64 | 12×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 3×NAG; 18×NAG; 3×SO4; | |||
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution data… |
Heteromer F5HCP3; F5HET4; P16837; Q68674; Q6GMX0; Q6SW67; | 85.13 | 1×NAG; 5×NAG; | |||
Crystal Structure of sErbB3-Fab3379 Complex |
Heteromer P21860; | 90.06 | 2×NAG; | |||
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6 |
Heteromer F5HCP3; F5HET4; P16837; Q68674; Q6SW67; Q8TCD0; | 72.31 | 3×NAG; 2×NAG; 1×NAG; | |||
B41 SOSIP.664 in complex with the silent-face antibody SF12 and V3-targeting antibody 10-1074 |
Heteromer B3UES2; B3UEZ6; Q8N5F4; | 48.15 | 1×NAG; 3×NAG; 5×NAG; 15×NAG; 6×NAG; 1×NAG; 33×NAG; | |||
Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab |
Heteromer A0A2H4K974; Q8TCD0; | 70.91 | 1×NAG; 26×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 2×NAG; 1×NAG; 1×NAG; 21×NAG; | |||
2 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7elx.1.A | monomer | 0.80 | 93.99 | |||
8a64.1.B | monomer | 0.68 | 92.17 | |||